Marsh & McLennan Companies, Inc.
NYSE:MRSHInsurance - Brokers
-$2.87 today
- Market cap
- $98.03B
- Beta
- 0.61
- P/E (TTM)
- 19.9
- EPS (TTM)
- $8.11
- Dividend yield
- 2.23%
Volume 1.40M
Average 3.00M
MRSH Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Marsh & McLennan Companies, Inc.NYSE: MRSH
Accounts Receivables · Q3 FY2026 · quarter ended Sep 2026
Accounts receivables grows, but more slowly than its trailing trend
Q3 FY2026 accounts receivables of $1.37B rose 156.1% year over year, behind the +1241.2% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -36.2% a year.
Context
- Accounts receivables amounted to 0.5% of revenue in FY2025, down 1.4 pp from a year earlier.
- Accounts receivables grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +156.1% toward the trailing-twelve-month pace of +1241.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (128M) USD
- Year-over-year change
- +72.6%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (128M) | +72.6% |
| FY2024 | 2024-12-31 | (467M) | +0.0% |
| FY2023 | 2023-12-31 | (467M) | +5.1% |
| FY2022 | 2022-12-31 | (492M) | -95.2% |
| FY2021 | 2021-12-31 | (252M) | — |
Accounts Receivables vs competitors
How MRSH compares with its peers on the latest reported figures
- MRSH's LTM Sep 2026 accounts receivables of $388M is the 3rd largest of the 7 companies compared; the peer median is $214.5M.
- Its year-over-year change of +1241.2% is the highest of 7, against a peer median of +90.6%.
- Accounts receivables amounts to 1.4% of revenue for MRSH, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $545.9M | +97.1% | -61.3% | 3.5% | |
| LTM Jun 2026 | $535M | +109.8% | +38.9% | 3.0% | |
| LTM Sep 2026 | $388M | +1241.2% | -36.2% | 1.4% | |
| LTM Jun 2026 | $232M | +84.1% | -12.0% | 2.3% | |
| LTM Sep 2026 | $197M | -111.8% | — | 2.8% | |
| LTM Jun 2026 | $40.79M | +200.1% | +41.4% | 1.3% | |
| LTM Sep 2026 | $16.41M | -82.8% | -37.3% | 0.9% | |
| Peer median (excluding MRSH) | $214.5M | +90.6% | -12.0% | 2.6% | |
Competitors are the stored peer set for MRSH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 3.17B | 3.09B | 3.8B | 4.06B | 4.23B |
| Depreciation & Amortization | 747M | 719M | 713M | 746M | 910M |
| Deferred Income Tax | (63M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 348M | 367M | 363M | 368M | 394M |
| Change in Working Capital | (645M) | (1.01B) | (908M) | (1.08B) | (518M) |
| Accounts Receivables | (252M) | (492M) | (467M) | (467M) | (128M) |
| Inventory | 252M | 0 | 0 | 0 | 0 |
| Accounts Payables | 225M | 0 | 0 | 0 | 0 |
| Other Working Capital | (870M) | (520M) | (441M) | (608M) | (390M) |
| Other Non-Cash Items | (45M) | 304M | 288M | 203M | 272M |
| Operating Cash Flow | 3.52B | 3.47B | 4.26B | 4.3B | 5.29B |
| Capital Expenditures | (406M) | (470M) | (416M) | (316M) | (291M) |
| Acquisitions (Net) | (775M) | (453M) | (993M) | (8.45B) | (652M) |
| Purchases of Investments | 406M | (22M) | (57M) | (108M) | (24M) |
| Sales of Investments | 17M | 86M | 38M | 55M | 100M |
| Other Investing Activities | (406M) | 9M | 11M | 1M | 22M |
| Investing Cash Flow | (1.16B) | (850M) | (1.42B) | (8.82B) | (845M) |
| Debt Repayment | (273M) | 619M | 1.9B | 6.55B | (519M) |
| Common Stock Issued | 161M | 126M | 199M | 264M | 250M |
| Common Stock Repurchased | (1.16B) | (1.95B) | (1.15B) | (900M) | (2.01B) |
| Dividends Paid | (1.03B) | (1.14B) | (1.3B) | (1.51B) | (1.7B) |
| Other Financing Activities | 1B | 1.62B | (426M) | 51M | (654M) |
| Financing Cash Flow | (1.3B) | (1.05B) | (1.12B) | 4.46B | (4.63B) |
| Effect of Forex Changes | (355M) | (841M) | 328M | (414M) | 673M |
| Net Change in Cash | 700M | 728M | 2.05B | (478M) | 486M |
| Free Cash Flow | 3.11B | 3B | 3.84B | 3.99B | 5B |
Marsh & McLennan Companies, Inc.
NYSE:MRSH
Intrinsic Alpha fair value
Locked
Current Price
$205.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.